Skip to main content
ACG 2025 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
ACG Health Equity Research Abstract of Distinction Award
ACG Health Equity Research Abstract of Distinction Award
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Website

NeurAxis, Inc.

NeurAxis provides innovative technologies to support personalized care and to make informed clinical decisions in the following patient populations:
•	Patients suffering from chronic constipation
•	Patients with disorders of the gut-brain interaction (DBGIs)
At ACG 2025, NeurAxis will focus on a novel screening tool for patients suffering from chronic constipation. RED (Rectal Expulsion Device) enables an efficient, office-based, anorectal test without the capital investment to help guide clinical decision making. Stop by booth 559 to learn more. For important information, indications, contraindications, and precautions, go to: https://red4constipation.com/

NeurAxis, Inc.
11611 North Meridian Street
Suite 330
Carmel, IN 46032

Telephone: (812) 689-0791